IL5 and breast carcinoma: We show that IL-3, IL-5, and GM-CSF released by Th2 cells are responsible for the induction of terminal differentiation in the developing breast cancer and demonstrate that Th2 cell immunity reverted high-grade breast cancers into low-grade, fibrocystic-like structures.